TSX:MSCL - Post Discussion
Post by
db2067 on Nov 25, 2021 10:10pm
U of T Gilbert lab
U of T Gilbert lab: Development of a personalized in-vitro model for dystrophic muscle endogenous repair for drug discovery https://www.mitacs.ca/en/projects/development-personalized-vitro-model-dystrophic-muscle-endogenous-repair-drug-discovery
Satellos Bioscience Inc is developing small molecule drugs that target and modulate DMD muscle stem cells to repair the dystrophic muscle. --- This project aims to develop a feasible model to bridge the gap between animal experiments and human clinical trials and enable Satellos to identify drug candidates most likely to ultimately succeed in clinical trials.
Be the first to comment on this post